Atrial Fibrillation Clinical Trial
Official title:
COVIDAR - International Registry on Arrhythmias in COVID-19
BACKGROUND AND RATIONALE: There is very limited literature available on the arrhythmia
occurrence in the context of an infection by the SARS-CoV2 virus. On the other hand,
treatment strategies against the SARS-CoV2 virus may carry a risk of QTc prolongation and
pro-arrhythmia/sudden death which may be amplified by concomitant use of other QTc-prolonging
drugs and/or ion disbalances. COVIDAR is an international initiative to monitor the
occurrence of arrhythmic events in the context of the SARS-CoV2 infection, to identify
potential modifiable predisposing factors to reduce their incidence and to inform the best
arrhythmia management options in this patient population.
MAIN OBJECTIVE: To describe the incidence and type of arrhythmic events in the context of the
SARS-CoV2 infection.
STUDY DESIGN: patient registry (observational). Patients will not undergo any additional
investigations. Only data that is generated during routine clinical care will be collected.
STUDY POPULATION: Patients admitted to the hospital highly suspected of or with confirmed
COVID-19.
The COVIDAR Registry is an international longitudinal multicentre observational study
worldwide which aims to assess the incidence, type and risk factors of arrhythmias in the
context of SARS-CoV2 infection, also providing relevant information on events/management and
major cardiovascular outcomes. During the course of the registry patients will be followed up
according to the usual practice of the centres. Drug prescriptions and indications to perform
diagnostic/therapeutic procedures will be completely left to the treating physicians.
The registry population will consist of patients presenting with a suspicion of SARS-CoV2
infection, who are hospitalised in a medical or surgical department of the participating
hospitals. Patients will officially be enrolled in the COVIDAR Registry if the COVID-19
disease has formally been noted or confirmed in the patient's medical record.
The registry will include all patients and collect data at the following timepoints:
- Admission: evaluation before SARS-CoV2 infection treatment initiation
- On-treatment: evaluation 24-28h after treatment initiation
- At any adverse event: evaluation if any adverse event occurs
- At discharge: evaluation of clinical status at the end of the admission period.
;
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT05654272 -
Development of CIRC Technologies
|
||
Completed |
NCT04571385 -
A Study Evaluating the Efficacy and Safety of AP30663 for Cardioversion in Participants With Atrial Fibrillation (AF)
|
Phase 2 | |
Terminated |
NCT04115735 -
His Bundle Recording From Subclavian Vein
|
||
Completed |
NCT05366803 -
Women's Health Initiative Silent Atrial Fibrillation Recording Study
|
N/A | |
Completed |
NCT02864758 -
Benefit-Risk Of Arterial THrombotic prEvention With Rivaroxaban for Atrial Fibrillation in France
|
||
Recruiting |
NCT05442203 -
Electrocardiogram-based Artificial Intelligence-assisted Detection of Heart Disease
|
N/A | |
Completed |
NCT05599308 -
Evaluation of Blood Pressure Monitor With AFib Screening Feature
|
N/A | |
Completed |
NCT03790917 -
Assessment of Adherence to New Oral anTicoagulants in Atrial Fibrillation patiEnts Within the Outpatient registrY
|
||
Enrolling by invitation |
NCT05890274 -
Atrial Fibrillation (AF) and Electrocardiogram (EKG) Interpretation Project ECHO
|
N/A | |
Recruiting |
NCT05266144 -
Atrial Fibrillation Patients Treated With Catheter Ablation
|
||
Recruiting |
NCT05316870 -
Construction and Effect Evaluation of Anticoagulation Management Model in Atrial Fibrillation
|
N/A | |
Not yet recruiting |
NCT06023784 -
The Impact of LBBAP vs RVP on the Incidence of New-onset Atrial Fibrillation in Patients With Atrioventricular Block
|
N/A | |
Recruiting |
NCT05572814 -
Transform: Teaching, Technology, and Teams
|
N/A | |
Recruiting |
NCT04092985 -
Smart Watch iECG for the Detection of Cardiac Arrhythmias
|
||
Completed |
NCT04087122 -
Evaluate the Efficiency Impact of Conducting Active Temperature Management During Cardiac Cryoablation Procedures
|
N/A | |
Completed |
NCT06283654 -
Relieving the Emergency Department by Using a 1-lead ECG Device for Atrial Fibrillation Patients After Pulmonary Vein Isolation
|
||
Recruiting |
NCT05416086 -
iCLAS™ Cryoablation System Post-Market Clinical Follow-up (PMCF) Study
|
N/A | |
Completed |
NCT05067114 -
Solutions for Atrial Fibrillation Edvocacy (SAFE)
|
||
Completed |
NCT04546763 -
Study Watch AF Detection At Home
|
||
Completed |
NCT03761394 -
Pulsewatch: Smartwatch Monitoring for Atrial Fibrillation After Stroke
|
N/A |